The objective of this contract is to develop and conduct appropriate ivrt, ivpt, in vivo animal model PK and drug distribution studies, and/or in vivo animal model PD studies of locally-acting topical…

Ended Indefinite Delivery Contract Awarded Sep 3, 2019 Last action Sep 27, 2023

Contract number: 75F40119D10024
Awardee: Pharmaron (Exton) Lab Services LLC UEI G7FBJ3M3JFF3
Awarding agency: Food and Drug Administration Department of Health and Human Services
Task orders: 3 $2,382,835 obligated

Award facts

Opportunity: 19223SOL00023 Solicitation number

In Vitro and Non-Clinical Evaluation of Locally-Acting Topical Dermal and Ophthalmic Formulation Properties Award Notice · Posted Apr 15, 2019
Combined order value: $2,382,835 Current and potential, with all options
Last date to order 100% complete: Sep 5, 2024
IDV ceiling 68% used: $3,500,000.00
Maximum order: $3,500,000.00
Award type: Single award
Who can order: Only the awarding agency
Contracting staff: Ian Weiss
NAICS code: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC: AJ51 R&D- General Science/Technology: Life Sciences (Basic Research)
Set-aside: Total Small Business
Competition: Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
Pricing: Order Dependent (IDV only)
Legislative mandates: Service Contract Inventory FAR subpart 4.17

Award details come from SAM.gov/FPDS.

Description

As the agency reported it.

The objective of this contract is to develop and conduct appropriate ivrt, ivpt, in vivo animal model PK and drug distribution studies, and/or in vivo animal model PD studies of locally-acting topical dermal and ophthalmic drug product formulations.

Task orders

Task order	Ordering agency	Obligated	Awarded
Permeability assessments of BCS class 3 drug substances in the presence of antioxidants. 75F40122F19003	Food and Drug Administration	$472,619	May 3, 2022
PK/PD of topically administered ophthalmic IOP drug formulations in rabbit 75F40120F19002	Food and Drug Administration	$1,574,070	Sep 29, 2020
The objective of this task order is to measure the tear film thickness and menisci of a rabbit ocular surface after… 75F40119F19001	Food and Drug Administration	$336,146	Sep 12, 2019

Transactions

Action	Obligated	Date
Novation Agreement P00001 · Updating the name change of the vendor from absorption systems california LLC 1547279 to pharmaron ( SAN deigo) lab services .	$0	Sep 27, 2023
Original award	$0	Sep 3, 2019

Quick answers

Who was awarded contract 75F40119D10024?

75F40119D10024 was awarded to Pharmaron (Exton) Lab Services LLC by Food and Drug Administration (Department of Health and Human Services) on September 3, 2019.

How much is contract 75F40119D10024 worth?

Orders under 75F40119D10024 have obligated $2,382,835. 75F40119D10024's own ceiling is $3,500,000. A single order can be worth up to $3,500,000.

How many orders have been placed under contract 75F40119D10024?

3 orders have been placed under 75F40119D10024, the latest on May 3, 2022.

Who can order from contract 75F40119D10024?

75F40119D10024 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75F40119D10024 competed?

The extent of competition for 75F40119D10024 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this IDV's full record

Every order and transaction
The awardee's other awards and teaming partners
Similar IDVs and recompete opportunities
Ask GovTribe AI about this IDV

Try for free Login